Major Changes to Berkshire’s Portfolio During Third Quarter
In an SEC 13-F filing after the market closed today, Berkshire reported the following major changes to its portfolio:
New Positions:
Merck ($1.9 billion) (Warren Buffett)
AbbVie ($1.9 billion) (Buffett)
Bristol-Myers Squibb ($1.8 billion) (Buffett)
T-Mobile ($275 million) (Todd Combs or Ted Weschler)
Pfizer ($136 million) (Combs or Weschler)
Additions to Previous Positions:
General Motors ($175 million) (Combs or Weschler)
Kroger ($175 million) (Combs or Weschler)
Sale of Position
Costco ($1.5 billion) (Charlie Munger or Buffett)
Reduction of Positions
Apple ($4 billion) (Buffett)
Wells Fargo ($3 billion) (Buffett)
JPMorgan Chase ($2 billion) (Buffett)
PNC Financial ($400 million) (Buffett)
Barrick Gold ($200 million) (Combs or Weschler)
M&T Bank ($150 million) (Buffett)